LMD welcomes ‘Smartphone-as-Medical-Instrument’ trend and highlights need for clinical accuracy
V-Sensor health sensor and app to enter final phase of clinical trial early in 2018
December 20, 2017, Lausanne, Switzerland: Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has welcomed news that other companies are entering the market, and at the same time has sounded a note of caution concerning medical accuracy and the need for calibration.
Comments Mark-Eric Jones, Founder & CEO of LMD: “We are tremendously excited that prominent companies are actively promoting the ubiquitous smartphone as a sophisticated and potentially life-saving medical tool. The recent announcement by Taiwanese company MediaTek shows the degree of confidence that industry has in this approach.”